Keywords
Aedes albopictus
dengue
dengue virus
dengue fever
Categories
How to Cite
Abstract
This publication provides an overview of dengue fever, focusing on its epidemiological landscape in Florida. Dengue, caused by dengue virus and transmitted through the bites of infected Aedes mosquitoes, is a major global health concern. Florida has experienced local dengue transmissions, and the incidence of dengue is increasing in the state. The biology and ecology of the primary vectors, Aedes aegypti and Aedes albopictus, play important roles in the disease's transmission cycle. No vaccine and no specific antiviral treatments are yet available, and diagnosis is difficult because dengue symptoms overlap with those of other, similar febrile illnesses. Prevention and control strategies, such as mosquito management, are therefore crucial to mitigate disease risks. Alongside urbanization, climate change, and globalization, incidence of dengue is increasing in Florida. Continued vigilance and research will help to combat this public health threat.
References
Achee, N. L., F. Gould, T. A. Perkins, R. C. Reiner Jr, A. C. Morrison, S. A. Ritchie, D. J. Gubler, R. Teyssou, and T. W. Scott. 2015. “A Critical Assessment of Vector Control for Dengue Prevention.” PLOS Neglected Tropical Diseases 9 (5): e0003655. https://doi.org/10.1371/journal.pntd.0003655.
Alagarasu, K., J. A. Patil, M. B. Kakade, A. M. More, B. Yogesh, P. Newase, S. M. Jadhav, et al. 2021. “Serotype and Genotype Diversity of Dengue Viruses Circulating in India: A Multi-Centre Retrospective Study Involving the Virus Research Diagnostic Laboratory Network in 2018.” International Journal of Infectious Diseases 111:242–252. https://doi.org/10.1016/j.ijid.2021.08.045.
Bhatt, P., P. S. Sabeena, M. Varma, and A. Govindakarnavar. 2021. “Current Understanding of the Pathogenesis of Dengue Virus Infection.” Current Microbiology 78 (1): 17–32. https://doi.org/10.1007/s00284-020-02284-w.
Bhatt, S., P. W. Gething, O. J. Brady, J. P. Messina, A. W. Farlow, C. L. Moyes, J. M. Drake, et al. 2013. “The Global Distribution and Burden of Dengue.” Nature 496 (7446): 504–507. https://doi.org/10.1038/nature12060.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD). 2024. Areas with Risk of Dengue. https://www.cdc.gov/dengue/areas-with-risk/?CDC_AAref_Val=https://www.cdc.gov/dengue/areaswithrisk/around-the-world.html.
Deng, S. Q., X. Yang, Y. Wei, J. T. Chen, X. J. Wang, and H. J. Peng. 2020. “A Review on Dengue Vaccine Development.” Vaccines 8 (1): 63. https://doi.org/10.3390/vaccines8010063.
Di Lorenzo P (2024). _usmap: US Maps Including Alaska and Hawaii_. R package version 0.7.1, <https://CRAN.R-project.org/package=usmap>.
Erlanger, T. E., J. Keiser, and J. Utzinger. 2008. “Effect of Dengue Vector Control Interventions on Entomological Parameters in Developing Countries: A Systematic Review and Meta‐Analysis.” Medical and Veterinary Entomology 22 (3): 203–221. https://doi.org/10.1111/j.1365-2915.2008.00740.x
Flores, H. A., and S. L. O’Neill. 2018. “Controlling Vector-Borne Diseases by Releasing Modified Mosquitoes.” Nature Reviews Microbiology 16 (8): 508–518. https://doi.org/10.1038/s41579-018-0025-0.
Guzman, M. G., D. J. Gubler, A. Izquierdo, E. Martinez, and S. B. Halstead. 2016. “Dengue Infection.” Nature Reviews Disease Primers 2 (1): 1–25. https://doi.org/10.1038/nrdp.2016.55.
Guzman, M. G., and E. Harris. 2015. “Dengue.” The Lancet 385 (9966): 453–465. https://doi.org/10.1016/S0140-6736(14)60572-9.
Hussain, Z., S. Rani, F. Ma, W. Li, W. Shen, T. Gao, J. Wang, and R. Pei. 2023. “Dengue Determinants: Necessities and Challenges for Universal Dengue Vaccine Development.” Review in Medical Virolology 33 (2): e2425. https://doi.org/10.1002/rmv.2425.
Kondapaneni, R., A. N. Malcolm, B. M. Vazquez, E. Zeng, T. Y. Chen, K. J. Kosinski, A. L. Romero-Weaver, et al. 2021. “Mosquito Control Priorities in Florida—Survey Results from Florida Mosquito Control Districts.” Pathogens. 10 (8): 947. https://doi.org/10.3390/pathogens10080947.
Moise, I. K., R. D. Xue, L. C. Zulu, and J. C. Beier. 2020. “A Survey of Program Capacity and Skills of Florida Mosquito Control Districts to Conduct Arbovirus Surveillance and Control.” Journal of the American Mosquito Control Association 36 (2): 99–106. https://doi.org/10.2987/20-6924.1.
Murray, N. E. A., M. B. Quam, and A. Wilder-Smith. 2013. “Epidemiology of Dengue: Past, Present and Future Prospects.” Clinical Epidemiology 5:299–309. https://doi.org/10.2147/CLEP.S34440.
Patel, S. S., P. Winkle, A. Faccin, F. Nordio, I. LeFevre, and C. G. Tsoukas. 2023. An Open-Label, Phase 3 Trial of TAK-003, a Live Attenuated Dengue Tetravalent Vaccine, in Healthy US Adults: Immunogenicity and Safety when Administered during the Second Half of a 24-Month Shelf-Life.” Human Vaccines and Immunotherapeutics 19 (2): 2254964. https://doi.org/10.1080/21645515.2023.2254964
Pebesma, E., 2018. Simple Features for R: Standardized Support for Spatial Vector Data. The R Journal 10 (1), 439-446, https://doi.org/10.32614/RJ-2018-009
Pebesma, E., & Bivand, R. (2023). Spatial Data Science: With Applications in R. Chapman and Hall/CRC. https://doi.org/10.1201/9780429459016.
Posit team (2024). RStudio: Integrated Development Environment for R. Posit Software, PBC, Boston, MA. URL http://www.posit.co/.
R Core Team (2024). _R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria. <https://www.R-project.org/>.
Rivera, A., L. E. Adams, T. M. Sharp, J. A. Lehman, S. H. Waterman, and G. Paz-Bailey. 2020. “Travel-Associated and Locally Acquired Dengue Cases — United States, 2010–2017.” Morbidity and Mortality Weekly Report Surveillance Summaries 69 (6): 149–154. https://doi.org/10.15585/mmwr.mm6906a1.
Ryff, K. R., A. Rivera, D. M. Rodriguez, G. A. Santiago, F. A. Medina, E. M. Ellis, J. Torres, A. Pobutsky, J. Munoz-Jordan, G. Paz-Bailey, L. E. Adams. 2023. “Epidemiologic Trends of Dengue in U.S. Territories, 2010–2020.” Morbidity and Mortality Weekly Report Surveillance Summaries 72 (4): 1–11. https://doi.org/10.15585/mmwr.ss7204a1.
Shepard, D. S., E. A. Undurraga, Y. A. Halasa, and J. D. Stanaway. 2016. “The Global Economic Burden of Dengue: A Systematic Analysis.” The Lancet Infectious Diseases 16 (8): 935–941. https://doi.org/10.1016/S1473-3099(16)00146-8.
Silva, J. P., and A. Fernandez-Sesma. 2023. “Challenges on the Development of a Dengue Vaccine: A Comprehensive Review of the State of the Art.” Journal of General Virology 104 (3): 001831. https://doi.org/10.1099/jgv.0.001831.
Tully, D., and C. L. Griffiths. 2021. “Dengvaxia: The World’s First Vaccine for Prevention of Secondary Dengue.” Therapeutic Advances in Vaccines and Immunotherapy. 9:25151355211015839. https://doi.org/10.1177/25151355211015839.
Utarini, A., C. Indriani, R. A. Ahmad, W. Tantowijoyo, E. Arguni, M. R. Ansari, E. Supriyati, D. S. Wardana, Y. Meitika, and I. Ernesia. 2021. “Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue.” New England Journal of Medicine 384 (23): 2177–2186. https://doi.org/10.1056/NEJMoa2030243
Wilder-Smith, A., E. Ooi, O. Horstick, and B. Wills. 2019. “Dengue.” The Lancet 393 (10169): 350–363. https://doi.org/10.1016/S0140-6736(18)32560-1.
Yang, X., M. B. M. Quam, T. Zhang, and S. Sang. 2021. “Global Burden for Dengue and the Evolving Pattern in the Past 30 Years.” Journal of Travel Medicine 28 (8): taab146. https://doi.org/10.1093/jtm/taab146.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 UF/IFAS